NADPH oxidase is the source of ROS in STZ rat aorta : use of the novel highly selective NOX inhibitor VAS2870 by Dugic, Elma et al.
YLS2013 Cardiovascular Medicine: Bridging Basic and Clinical Researchers 
Title 
NADPH oxidase is the source of ROS in STZ rat aorta; use of the novel highly selective NOX 
inhibitor VAS2870 
 
Authors (please underline presenting author) 
Elma Dugic, Yousif Shamsaldeen, Christopher Benham, Louise S Mackenzie 
Affiliations (please include email address of presenting author) 
elmdu212@student.liu.se 
Division of Biosciences, School of Life and Medical Sciences, University of Hertfordshire 
 
Are you willing for this abstract to be considered for ORAL presentation (please delete one)?  NO 
 
Abstract text (max 400 words) 
Abnormal vascular responsiveness in diabetes has been attributed to a number of changes in 
contractile and dilatory pathways, affected in part by the overproduction of reactive oxygen species 
(ROS). It has been reported that NADPH oxidase (NOX) is increased in endothelial cells of 
streptozotocin (STZ) treated rats, a model of diabetes. However pharmacological tools used in NOX 
studies are of limited use; the NOX inhibitor apocynin is non-selective and has off-target effects1 and 
may inhibit nitric oxide synthase. Here we use the novel, highly selective NOX inhibitor VAS28702 to 
confirm the source of ROS in aorta of STZ rats. 
Male Wistar rats (250 to 350g) were injected with 65mg/kg STZ; development of diabetes was 
confirmed after 5 days by testing blood glucose levels. Rats were killed by CO2 asphyxiation, and 
the thoracic aorta removed and cleaned for mounting in a 20ml organ bath. Aorta were tensioned to 
1g, equilibrated and incubated with 10-5M VAS2870, 10-5M apocynin, 150U/ml superoxide 
dismutase (SOD) or vehicle control (0.1% DMSO) in Kreb’s buffer for 30 minutes, followed by an 
increasing concentration of phenylephrine (PE).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Response curve to PE in control and STZ treated rats (A); aorta responses to PE 
following incubation with VAS2870 in aorta from control (B) and STZ treated (C) rats.  ***p=<0.001 
significance by two way ANOVA; n=4 for all groups 
PE induced contraction of STZ rat aorta is significantly increased in comparison to control rat aorta 
(Figure 1A). Incubation with VAS2870had no effect on PE induced contraction in control rat aorta 
(figure 1B), and significantly reduced contraction in STZ treated rat aorta to a level consistent with 
control rat aorta (figure 1C). In contrast, the apocynin had no significant effect on aorta from either 
type of rat. Contraction following incubation with SOD had no effect on control rat aorta (– SOD 
EC50 = 1.8x10-8M, Emax=0.353 ± 0.016g; +SOD EC50 = 2.5x10-8M, Emax= 0.338 ± 0.051g), and in 
contrast significantly reduced the contraction in STZ rat aorta (-SOD EC50 = 6.5x10-9M, Emax= 0.460 
±0.067; +SOD EC50 = 1.5x10-8M, Emax= 0.322 ± 0.037g). 
VAS2870 reduces the PE overcontraction that is also reduced by SOD. This is consistent with the 
idea that the enhanced contraction is primarily due to ROS generated by NOX, and is the first report 
of the NOX inhibitor VAS2870 in STZ treated rats. 
1Heumuller et al, Hypertension 2008, 2ten Freyhaus et al, Cardiovasc Res 2006  
 
 
-10 -9 -8 -7 -6 -5 -4
0.0
0.2
0.4
0.6
Control +DMSO
Control rat +VAS2870
*
B.
[PE] Log Mol
C
on
tra
ct
io
n 
(g
)
-10 -9 -8 -7 -6 -5 -4
0.0
0.2
0.4
0.6
STZ rat + DMSO
STZ rat + VAS2870
***
C.
[PE] Log Mol
C
on
tra
ct
io
n 
(g
)
-10 -9 -8 -7 -6 -5 -4
0.0
0.2
0.4
0.6
Control + vehicle
STZ + vehicle
***
A.
[PE] Log Mol
C
on
tra
ct
io
n 
(g
)
